Literature DB >> 16704536

Higher cut-off index value of immunoglobulin M antibody to hepatitis B core antigen in Taiwanese patients with hepatitis B.

Yi-Wen Huang1, Chih-Lin Lin, Pei-Jer Chen, Ming-Yang Lai, Jia-Horng Kao, Ding-Shinn Chen.   

Abstract

BACKGROUND: The cut-off index value of immunoglobulin M (IgM) antibody to hepatitis B core antigen (anti-HBc; AxSYM CORE-M, Abbott) for diagnosing acute hepatitis B is 1.2. A high false-positive rate of IgM anti-HBc was observed in acute flare-ups of chronic hepatitis B in Taiwanese patients. Thus the purpose of the present paper was to study the optimal index value of IgM anti-HBc in Taiwanese subjects.
METHODS: The peak index values of 42 IgM anti-HBc-positive patients were collected. There were 20 acute hepatitis B patients and 22 patients with chronic hepatitis B with acute flare. The biochemical, virological, and serological data were obtained.
RESULTS: There were significant differences in mean age (36 vs 47 years, P = 0.01), serum alanine aminotransferase level (2042 U/L vs 1193 U/L, P = 0.02) and peak index value of IgM anti-HBc (2.9 vs 1.5, P < 0.01) between patients with acute hepatitis B and those with acute flare of chronic hepatitis B. Eleven (50%) of 22 patients with chronic hepatitis B with acute flare had index value of >1.2. The optimal cut-off index value to differentiate acute hepatitis B from chronic hepatitis B with acute flare was 2.4-2.5, with a sensitivity of 90% and specificity of 90%.
CONCLUSIONS: The cut-off index value of IgM anti-HBc to differentiate acute hepatitis B from chronic hepatitis B with acute flare among Taiwanese patients should be set at 2.4-2.5 instead of 0.8-1.2.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16704536     DOI: 10.1111/j.1440-1746.2006.04280.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  6 in total

1.  Two distinct subtypes of hepatitis B virus-related acute liver failure are separable by quantitative serum immunoglobulin M anti-hepatitis B core antibody and hepatitis B virus DNA levels.

Authors:  Doan Y Dao; Linda S Hynan; He-Jun Yuan; Corron Sanders; Jody Balko; Nahid Attar; Anna S F Lok; R Ann Word; William M Lee
Journal:  Hepatology       Date:  2012-01-31       Impact factor: 17.425

2.  Differentiation of acute and chronic hepatitis B in IgM anti-HBc positive patients.

Authors:  Ji Won Park; Kyeong Min Kwak; Sung Eun Kim; Myoung Kuk Jang; Dong Joon Kim; Myung Seok Lee; Hyoung Su Kim; Choong Kee Park
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

3.  A k-mer scheme to predict piRNAs and characterize locust piRNAs.

Authors:  Yi Zhang; Xianhui Wang; Le Kang
Journal:  Bioinformatics       Date:  2011-01-11       Impact factor: 6.937

Review 4.  Review of hepatitis B surveillance in China: improving information to frame future directions in prevention and control.

Authors:  Fuqiang Cui; Jan Drobeniuc; Stephen C Hadler; Yvan J Hutin; Fubao Ma; Steve Wiersma; Fuzhen Wang; Jiang Wu; Hui Zheng; Liwei Zhou; Shuyan Zuo
Journal:  Vaccine       Date:  2013-06-12       Impact factor: 3.641

Review 5.  Acute hepatitis B virus infection or acute exacerbation of chronic hepatitis B infection: the differential serological diagnosis.

Authors:  R A A Pondé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-11-18       Impact factor: 3.267

6.  The dilemma of differentiating between acute hepatitis B and chronic hepatitis B with acute exacerbation: Is quantitative serology the answer?

Authors:  Sujata Lall; Pragya Agarwala; Guresh Kumar; Manoj Kumar Sharma; Ekta Gupta
Journal:  Clin Mol Hepatol       Date:  2020-04-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.